Home › Compare › BKEPP vs MRK

BKEPP vs MRK: Dividend Comparison 2026

BKEPP yields 81.93% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKEPP wins by $6.6K in total portfolio value
10 years
BKEPP
BKEPP
● Live price
81.93%
Share price
$8.74
Annual div
$7.16
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.3K
Annual income
$15.18
Full BKEPP calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — BKEPP vs MRK

📍 BKEPP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKEPPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKEPP + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BKEPP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKEPP
Annual income on $10K today (after 15% tax)
$6,963.87/yr
After 10yr DRIP, annual income (after tax)
$12.90/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $794.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKEPP + MRK for your $10,000?

BKEPP: 50%MRK: 50%
100% MRK50/50100% BKEPP
Portfolio after 10yr
$34.0K
Annual income
$482.74/yr
Blended yield
1.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BKEPP
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKEPP buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKEPPMRK
Forward yield81.93% ✓3.25%
Annual dividend / share$7.16 ✓$3.08
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR-50%8.2% ✓
Portfolio after 10y$37.3K ✓$30.7K
Annual income after 10y$15.18$950.29 ✓
Total dividends collected$10.4K ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BKEPP vs MRK ($10,000, DRIP)

YearBKEPP PortfolioBKEPP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,796$4,096.39$11,192$351.54+$3.6K → BKEPP
2$18,664$2,832.33$12,524$392.70+$6.1K → BKEPP
3$21,640$1,669.51$14,015$438.65+$7.6K → BKEPP
4$24,060$904.54$15,682$489.96+$8.4K → BKEPP
5$26,214$469.94$17,547$547.23+$8.7K → BKEPP
6$28,288$239.26$19,632$611.16+$8.7K → BKEPP
7$30,389$120.65$21,963$682.53+$8.4K → BKEPP
8$32,577$60.57$24,571$762.18+$8.0K → BKEPP
9$34,888$30.34$27,486$851.08+$7.4K → BKEPP
10$37,345$15.18$30,745$950.29+$6.6K → BKEPP

BKEPP vs MRK: Complete Analysis 2026

BKEPP — Stock

Blueknight Energy Partners, L.P. provides integrated terminalling services for companies engaged in the production, distribution, and handling of liquid asphalt in the United States. As of March 1, 2022, it had 54 terminals located in 26 states. Blueknight Energy Partners G.P., L.L.C. operates as a general partner of Blueknight Energy Partners, L.P. The company was formerly known as SemGroup Energy Partners, L.P. and changed its name to Blueknight Energy Partners, L.P. in December 2009. Blueknight Energy Partners, L.P. was incorporated in 2007 and is headquartered in Tulsa, Oklahoma.

Full BKEPP Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this BKEPP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKEPP vs SCHDBKEPP vs JEPIBKEPP vs OBKEPP vs KOBKEPP vs MAINBKEPP vs JNJBKEPP vs ABBVBKEPP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.